Your kidneys work silently. Every single day, they filter about 200 litres of blood, remove waste, balance fluids, and produce hormones that regulate blood pressure and red blood cell production. They never complain. They never stop. And because they are so quiet — because they do their job without ever demanding attention — the cancers that grow in them often go unnoticed for years.
This is the most important thing to understand about kidney cancer: it is one of the most silent cancers in the human body. In the early stages, it causes no pain, no visible changes, and no obvious symptoms. By the time most patients notice something wrong, the cancer has already grown significantly — or in some cases, spread to other organs.
And yet — here is the encouraging truth — when kidney cancer is detected early, the five-year survival rate is close to 93%. Even at Stage 2, survival rates remain strong. The challenge is simply finding it early enough.
In India, renal cell carcinoma (RCC) — the most common type of kidney cancer — accounts for approximately 3% of all cancers. While the incidence is relatively lower than in Western countries, the numbers have been rising steadily, partly due to better diagnostic imaging, increasing rates of obesity and hypertension, and greater awareness.
This complete guide covers everything about kidney cancer — what it is, the different types, symptoms to watch for, causes and risk factors, how it is diagnosed, the stages, all treatment options available in India, and how Doctor Visit Bangalore can help you access the best kidney cancer care in Bangalore and across India.
What Is Kidney Cancer?
Kidney cancer — also called renal cancer — develops when cells in the kidney grow abnormally and out of control, forming a tumour. If left untreated, this tumour can invade surrounding tissue, spread to nearby lymph nodes, and travel through the bloodstream to distant organs.
Your kidneys are two bean-shaped organs located in the back of your abdomen, one on each side of the spine, just below the rib cage. Each kidney contains millions of tiny filtering units called nephrons. Each nephron has tiny tubes called tubules — and it is in these tubules that the most common type of kidney cancer begins.
Most kidney cancers start in just one kidney. It is rare for kidney cancer to develop in both kidneys simultaneously — though it does happen in cases involving certain genetic conditions. Kidney cancer is also different from cancers that begin elsewhere in the body and later spread to the kidney — those are called secondary or metastatic cancers, and they are treated very differently.
Types of Kidney Cancer
Not all kidney cancers are the same. The type of kidney cancer determines the treatment approach, the prognosis, and the likelihood of responding to various therapies.
1. Renal Cell Carcinoma (RCC) — Most Common
Renal cell carcinoma is the most common type of kidney cancer in adults, accounting for approximately 85 to 90% of all kidney cancer cases in India and worldwide. RCC develops in the cells lining the tiny tubules inside the kidneys — the same tubes that filter blood and produce urine. RCC may affect one or both kidneys.
There are more than 50 subtypes of RCC, but the most clinically important ones are:
Clear Cell Renal Cell Carcinoma (ccRCC): The most common subtype — accounting for 70 to 75% of all RCC cases. The cancer cells appear clear under a microscope because they contain fat and glycogen. Clear cell RCC tends to respond well to targeted therapy and immunotherapy, which makes it one of the more treatable advanced kidney cancers with modern drugs.
Papillary Renal Cell Carcinoma (pRCC): The second most common subtype — accounting for 10 to 15% of RCC cases. There are two types: Type 1 (typically slower growing) and Type 2 (more aggressive). Papillary RCC is often multifocal — meaning multiple tumours can develop in the same kidney.
Chromophobe Renal Cell Carcinoma: A rarer subtype accounting for about 5% of RCC cases. Generally has a better prognosis than clear cell or papillary RCC and rarely metastasises.
Collecting Duct RCC: One of the rarest and most aggressive types of RCC. It forms in the collecting duct of the kidney, often does not show symptoms until advanced stages, and is frequently diagnosed as metastatic renal cell carcinoma. It has a poor prognosis.
Unclassified RCC: Heterogeneous tumour groups that cannot be classified under any of the above types. Unclassified RCC is reported to have the worst prognosis among all RCC subtypes.
Clear Cell Papillary RCC: Carries characteristics of both clear cell and papillary RCC. Can be detected in early stages and generally has a better prognosis than other subtypes.
2. Transitional Cell Carcinoma (Urothelial Carcinoma of the Renal Pelvis)
This type usually begins where the ureter connects to the kidney — in the renal pelvis — but it can also start in the ureter or bladder. It accounts for about 5 to 7% of kidney cancers. Transitional cell carcinoma behaves more like bladder cancer than kidney cancer and is treated similarly — often with chemotherapy and sometimes surgery.
3. Wilms Tumour (Nephroblastoma)
A rare type of kidney cancer that almost exclusively affects children — typically those younger than 5 years of age. It accounts for approximately 5% of kidney cancers. Wilms tumour is treated with surgery, radiation, and chemotherapy and generally has a very good prognosis — particularly when detected early.
4. Renal Sarcoma
The rarest form of kidney cancer, accounting for approximately 1% of cases. Renal sarcoma begins in the connective tissue or blood vessels of the kidney rather than in the kidney cells themselves. It is treated primarily with surgery and has a higher risk of recurrence than other kidney cancer types.
Symptoms of Kidney Cancer — What to Watch For
One of the most dangerous aspects of kidney cancer is how silent it can be. Kidney cancer does not always cause symptoms in the early stages. Many people are diagnosed when the cancer is found by accident during imaging tests done for another health issue.
As the tumour grows, symptoms gradually begin to appear. Here is what to watch for:
Blood in the urine (haematuria): This is the most common and most important symptom of kidney cancer. The blood may make the urine look pink, red, or dark brown — like rust-coloured water. In some cases, blood in the urine is microscopic and only detectable through a urine test. Haematuria can come and go — it may appear once and then disappear for weeks before returning. Any blood in the urine should be investigated by a doctor immediately.
Pain in the side or lower back: A dull, persistent ache in the flank — the area between the lower ribs and the hip, on one side — is a common symptom of kidney cancer. Unlike kidney stone pain — which is typically sharp and comes in waves — kidney cancer pain is usually constant and dull.
A lump or mass in the abdomen: Some patients or their doctors can feel a firm lump or mass in the abdomen or flank area. This is more commonly detected in thinner patients or when the tumour has grown significantly.
Unexplained weight loss: Significant, unintentional weight loss without dieting or increased activity can be a sign of kidney cancer or many other cancers. If you have lost more than 5% of your body weight without explanation over 6 to 12 months, see a doctor.
Persistent fatigue: Unusual and persistent tiredness that does not improve with rest — often caused by anaemia (low red blood cell count) related to the cancer.
Fever: Intermittent, unexplained fever — not related to any infection — that comes and goes over weeks or months.
High blood pressure (hypertension): Kidney cancer can cause newly developed or difficult-to-control high blood pressure, because the tumour may affect the kidney’s role in blood pressure regulation.
Anaemia: Low red blood cell counts — causing pallor, breathlessness, and fatigue — are common in kidney cancer, particularly in advanced stages.
Swelling in the legs or ankles: Caused by obstruction of the lymphatic vessels or veins by the tumour or metastatic lymph nodes.
Symptoms of advanced kidney cancer: When kidney cancer has spread to other organs, additional symptoms appear depending on the location — bone pain (bone metastases), cough or breathlessness (lung metastases), neurological symptoms (brain metastases), or abdominal fullness (liver metastases).
Causes and Risk Factors of Kidney Cancer
The exact cause of kidney cancer in any individual is rarely identifiable. What we know is that kidney cancer develops when cells in the kidney acquire genetic mutations that cause them to grow abnormally. Several factors significantly increase the risk.
Non-Modifiable Risk Factors
Age: Kidney cancer risk increases significantly with age. Most cases are diagnosed in people between 60 and 70 years old — though it can occur at any age. The average age of diagnosis is around 64.
Gender: Men are approximately twice as likely to develop kidney cancer as women. This may be partly due to higher rates of smoking, obesity, and occupational chemical exposure in men historically, though the gap is narrowing.
Family history: Having a first-degree relative — parent, sibling, or child — with kidney cancer increases your risk. First-degree relatives of patients with hereditary RCC syndromes face significantly elevated risk.
Genetic conditions: Several inherited conditions significantly increase kidney cancer risk. Von Hippel-Lindau (VHL) disease — a genetic disorder that causes tumours in multiple organs including the kidneys — is one of the most well-known. Other hereditary syndromes include hereditary papillary renal cell carcinoma, Birt-Hogg-Dubé syndrome, hereditary leiomyoma-renal cell carcinoma syndrome, and hereditary renal oncocytoma. People with these conditions should be in a regular surveillance programme for kidney cancer.
Race: African-Americans have a slightly higher risk of kidney cancer than other groups, though the reasons for this are not fully understood.
Modifiable Risk Factors
Smoking: Smokers have approximately double the risk of kidney cancer compared to non-smokers. The risk is dose-dependent — the more you smoke and the longer you have smoked, the higher your risk. Stopping smoking significantly reduces the risk over time.
Obesity: Obesity significantly increases the risk of kidney cancer. Excess body fat causes hormonal and metabolic changes that promote cancer development in the kidneys. Obesity, smoking, chronic kidney disease, alcohol consumption, and long-term dialysis are important risk factors for kidney cancer in India.
High blood pressure (hypertension): Hypertension is an independent risk factor for kidney cancer — separate from the medications used to treat it.
Advanced chronic kidney disease and long-term dialysis: Patients with advanced kidney disease who have been on dialysis for a long time have an elevated risk of developing renal cell cancer. Regular surveillance is recommended for long-term dialysis patients.
Occupational chemical exposure: Prolonged exposure to certain chemicals increases kidney cancer risk. These include cadmium, asbestos, organic solvents (particularly trichloroethylene), and certain herbicides. People who work in high-risk environments and are exposed to carcinogens regularly should use protective gear when working. According to the World Health Organisation, workplace carcinogen exposure is a significant preventable cancer risk.
Diuretics (water pills): Some research suggests that long-term use of certain diuretics may slightly increase kidney cancer risk, though this relationship is not fully established.
Stages of Kidney Cancer
Staging describes how far the cancer has grown and whether it has spread. This is the single most important factor in planning treatment and predicting outcomes.
Stage 1
The tumour is 7 cm or smaller and is confined entirely within the kidney. It has not spread to lymph nodes or other organs. This is the most treatable stage. Five-year survival rate: approximately 81 to 93%
Stage 2
The tumour is larger than 7 cm but is still confined within the kidney. It has not spread to lymph nodes or other organs. Five-year survival rate: approximately 74%
Stage 3
The cancer has spread beyond the kidney — either into the large vein leading from the kidney (renal vein or inferior vena cava), into the surrounding fat tissue, into the adrenal gland on the same side, or into nearby regional lymph nodes. It has not spread to distant organs. Five-year survival rate: approximately 53%
Stage 4
The cancer has spread beyond the surrounding tissue to distant lymph nodes or to other organs. The most common sites of kidney cancer metastasis are the lungs, bones, liver, and brain. Stage 4 includes any tumour that has grown through the fatty tissue surrounding the kidney and invaded nearby organs (except the adrenal gland). Five-year survival rate: approximately 8 to 12% — though modern targeted therapy and immunotherapy have significantly improved outcomes
How Is Kidney Cancer Diagnosed?
Because kidney cancer rarely causes obvious early symptoms, diagnosis often happens in one of two ways — either the cancer is found accidentally during imaging for another reason, or a patient presents with haematuria, flank pain, or another symptom that prompts investigation.
1. Urine Tests
A urinalysis can detect blood in the urine — either visible haematuria or microscopic haematuria (blood only detectable under a microscope). Urine cytology can look for abnormal cells in the urine — particularly useful if transitional cell carcinoma of the renal pelvis is suspected.
2. Blood Tests
Blood tests check kidney function (creatinine, eGFR), full blood count (checking for anaemia), liver function, calcium levels (elevated calcium can indicate advanced kidney cancer), and tumour markers where applicable.
3. Ultrasound
A non-invasive first-line imaging test. Ultrasound can detect kidney masses and help distinguish solid tumours (potentially cancerous) from fluid-filled cysts (usually benign). It is often the first imaging test done when kidney cancer is suspected.
4. CT Scan (Computed Tomography)
A CT scan with contrast is the gold standard for evaluating kidney tumours. It provides detailed information about the tumour’s size, location, involvement of blood vessels, and whether cancer has spread to nearby lymph nodes, adrenal glands, or other organs. A CT urogram evaluates the entire urinary tract.
5. MRI (Magnetic Resonance Imaging)
MRI provides detailed soft tissue imaging and is particularly useful for evaluating tumour extension into the renal vein or inferior vena cava — critical information for surgical planning. MRI is also used when CT contrast dye cannot be given due to allergy or kidney function concerns.
6. PET Scan
Used in selected cases — particularly for advanced or metastatic kidney cancer — to detect cancer spread to bones, lungs, or liver. PET scanning is also used to evaluate treatment response.
7. Biopsy
A biopsy — removing a small sample of tumour tissue for pathological examination — is not always necessary for kidney cancer, because CT and MRI imaging can often provide sufficient information for surgical planning. However, biopsy is used when the diagnosis is uncertain, when the tumour appearance is atypical, or when treatment with targeted therapy or immunotherapy is planned without surgery. For metastatic or advanced cases, a biopsy may be done using ultrasound or CT guidance to confirm cancer type and grade.
8. Bone Scan
For patients with bone pain or elevated alkaline phosphatase, a bone scan checks for skeletal metastases.
9. Chest CT
A CT scan of the chest is routinely performed in all kidney cancer patients to check for lung metastases — the most common site of kidney cancer spread.
Kidney Cancer Treatment Options
Kidney cancer treatment has been revolutionised over the past decade by the development of targeted therapies and immunotherapy — drugs that have transformed outcomes for advanced disease. Treatment depends on the stage, the tumour type, the patient’s overall health, and the number of kidneys affected.
1. Surgery — The Primary Treatment for Localised Kidney Cancer
Surgery is the main treatment for kidney cancer that is confined to the kidney or has limited local spread. The goal is complete removal of the tumour.
Radical Nephrectomy: Complete removal of the entire kidney — including the tumour, surrounding fatty tissue, adrenal gland, and nearby lymph nodes. Traditionally done through open surgery, it is now most commonly performed laparoscopically or robotically — allowing for faster recovery, less pain, and smaller scars. Radical nephrectomy is the standard treatment for large or centrally located tumours.
Partial Nephrectomy (Nephron-Sparing Surgery): Only the tumour and a margin of healthy tissue are removed — the rest of the kidney is preserved. This is preferred over radical nephrectomy whenever surgically feasible, because it preserves kidney function. Partial nephrectomy is the standard of care for tumours 4 cm or smaller (T1a) and is increasingly performed for tumours up to 7 cm in carefully selected patients. Most people can live a healthy, normal life with a single kidney — the remaining kidney adapts and takes over the function of both.
Robotic Partial Nephrectomy: The partial nephrectomy is performed using the Da Vinci robotic surgical system — providing greater surgical precision, better visualisation, reduced blood loss, and faster recovery. Robotic nephrectomy is available at several hospitals in Bangalore including Apollo, Aster CMI, and Manipal.
Cytoreductive Nephrectomy: In selected patients with metastatic kidney cancer, removing the primary kidney tumour — even though the cancer has spread — can improve the response to systemic therapy and in some cases prolong survival.
2. Ablative Therapies — For Small Tumours or High-Risk Patients
For patients who cannot undergo surgery due to other health problems, or for very small tumours, minimally invasive ablative treatments can destroy the tumour without removing it.
Radiofrequency Ablation (RFA): A needle is inserted into the tumour under CT or ultrasound guidance, and electrical current heats the tumour, destroying the cancer cells.
Cryoablation: A probe is inserted into the tumour and extreme cold is used to freeze and destroy the cancer cells.
These techniques are used in select cases — typically for small tumours (less than 3 cm) in patients who are not good surgical candidates.
3. Targeted Therapy — Revolutionising Advanced Kidney Cancer Treatment
Targeted therapies attack specific molecular pathways that kidney cancer cells depend on for growth and survival. They have dramatically improved outcomes for advanced and metastatic renal cell carcinoma compared to older treatments.
VEGF/VEGFR Inhibitors (Anti-angiogenic drugs): These drugs block the growth of blood vessels that feed the tumour. Key drugs include Sunitinib (Sutent), Pazopanib (Votrient), Axitinib (Inlyta), Cabozantinib (Cabometyx), and Lenvatinib. These are taken as daily oral tablets and are the most widely used first-line treatments for advanced clear cell RCC.
mTOR Inhibitors: Everolimus (Afinitor) and Temsirolimus block the mTOR pathway — a signalling pathway that promotes cancer cell growth. Used primarily as second-line therapy after VEGF inhibitors.
VEGF inhibitors are available in India at significantly lower cost than in Western countries — particularly generic versions of Sunitinib and Pazopanib — making India a very cost-effective destination for advanced kidney cancer treatment.
4. Immunotherapy — The New Standard for Advanced Kidney Cancer
Immunotherapy drugs — particularly immune checkpoint inhibitors — have transformed the treatment of advanced kidney cancer in the past decade. They work by blocking the brakes on the immune system, allowing it to recognise and attack cancer cells more effectively.
Nivolumab (Opdivo): An anti-PD-1 antibody approved for previously treated advanced RCC. Has shown significant survival benefit compared to older treatments.
Pembrolizumab (Keytruda) + Axitinib: A combination of immunotherapy and targeted therapy now approved as a first-line treatment for advanced clear cell RCC. Has shown superior survival outcomes compared to Sunitinib alone.
Nivolumab + Ipilimumab (Opdivo + Yervoy): A dual immunotherapy combination for intermediate and poor-risk advanced clear cell RCC. Produces durable responses in a subset of patients.
Pembrolizumab + Lenvatinib: Another combination recently approved for first-line advanced RCC with strong survival data.
These immunotherapy combinations are available at India’s top cancer centres including HCG, Apollo, Aster CMI, and Fortis in Bangalore.
5. Chemotherapy
Traditional chemotherapy has limited effectiveness in most kidney cancer types — particularly clear cell RCC, which is largely resistant to chemotherapy. However, chemotherapy is used for transitional cell carcinoma of the renal pelvis (which behaves more like bladder cancer) and for some rare kidney cancer subtypes. Chemotherapy combinations like MVAC (Methotrexate, Vinblastine, Doxorubicin, Cisplatin) or GC (Gemcitabine + Cisplatin) are used for urothelial carcinoma.
6. Radiation Therapy
Kidney cancer is generally not very sensitive to radiation therapy. However, radiation is used in kidney cancer for specific purposes — palliative radiation to painful bone metastases, stereotactic radiosurgery (SRS) for brain metastases, or to manage symptoms from tumour deposits in specific locations. Advanced radiation techniques like SBRT (Stereotactic Body Radiation Therapy) are increasingly used at Bangalore’s top cancer centres.
7. Active Surveillance (Watchful Waiting)
For small, incidentally discovered kidney tumours — particularly in elderly patients or those with significant health problems — active surveillance with regular imaging may be the appropriate initial approach. Many small kidney tumours grow slowly and may never require intervention. Active surveillance avoids the risks of surgery while monitoring for growth or progression that would trigger intervention.
Kidney Cancer Prevention — What You Can Do
While kidney cancer cannot always be prevented, there are meaningful steps to reduce risk:
Stop smoking: Smokers have double the risk of kidney cancer. Stopping smoking is the most impactful modifiable risk reduction step.
Maintain a healthy weight: Obesity is a major risk factor. Weight loss through diet and exercise significantly reduces kidney cancer risk.
Control blood pressure: Hypertension is an independent risk factor for kidney cancer. Effective blood pressure management reduces this risk.
Stay well hydrated: Drinking at least 2 litres of water daily helps the kidneys function properly and flushes out toxins. This may reduce kidney cancer risk.
Avoid occupational carcinogens: Workers in high-risk industries should use proper protective equipment. Avoid prolonged exposure to asbestos, cadmium, organic solvents, and other carcinogens.
Regular health screenings: People with known risk factors — hypertension, obesity, chronic kidney disease, family history, or genetic syndromes — should have regular kidney function tests and imaging as recommended by their doctor. Timely diagnosis and treatment improves patient outcomes.
Kidney Cancer Treatment Cost in India
India offers world-class kidney cancer treatment at a fraction of what it costs in Western countries:
| Treatment | Approximate Cost in India |
|---|---|
| Radical Nephrectomy (open) | ₹2,50,000 – ₹4,00,000 |
| Laparoscopic Nephrectomy | ₹3,00,000 – ₹5,00,000 |
| Robotic Partial Nephrectomy | ₹4,00,000 – ₹7,00,000 |
| Radiofrequency Ablation / Cryoablation | ₹1,50,000 – ₹3,00,000 |
| Targeted Therapy (per month) | ₹30,000 – ₹1,50,000 |
| Immunotherapy (per cycle) | ₹1,50,000 – ₹4,00,000 |
| Radiation — SBRT (full course) | ₹2,00,000 – ₹5,00,000 |
Compare this to the US where radical nephrectomy costs ₹10 to 25 lakh and immunotherapy costs ₹8 to 15 lakh per cycle. India offers the same quality at 80 to 90% lower cost.
Best Hospitals for Kidney Cancer Treatment in Bangalore
HCG Cancer Hospitals Bangalore — India’s largest dedicated cancer network specialises exclusively in oncology. Their uro-oncology department handles kidney cancer comprehensively — from early-stage robotic surgery through to advanced immunotherapy and targeted therapy combinations.
Apollo Hospitals Bangalore — Has a comprehensive uro-oncology programme with robotic surgical capability (Da Vinci system), experienced urological oncologists, and a strong medical oncology team for systemic treatments. JCI-accredited with dedicated international patient services.
Aster CMI Hospital Bangalore — Ranked #1 in Bangalore, Aster CMI has experienced uro-oncologists and a multidisciplinary tumour board approach. Strong for complex cases, robotic surgery, and comprehensive cancer care.
Fortis Hospital Bangalore — Strong urology and oncology departments with experienced surgeons and a comprehensive medical oncology team for targeted therapy and immunotherapy.
Manipal Hospitals Bangalore — Offers kidney cancer surgery, targeted therapy, and immunotherapy with experienced oncology teams across multiple locations in the city.
How Doctor Visit Bangalore Can Help
Whether you are in Bangalore, another city in India, or coming from abroad — Doctor Visit Bangalore connects you with the right uro-oncologist or urological surgeon for kidney cancer treatment quickly and easily.
We help with:
- Free specialist recommendation and appointment booking
- Understanding your imaging and biopsy reports
- Getting a second opinion before committing to treatment
- Transparent cost estimate within 24 hours
- Medical visa assistance for international patients
- Airport pickup and accommodation near the hospital
- Complete treatment coordination through surgery, targeted therapy, and immunotherapy
- Post-treatment surveillance appointment coordination
Our service is completely free. Contact us today.
📞 Call Now: +91 78920 28951 💬 WhatsApp: +91 78920 28951 📧 Info@doctorvisitbangalore.com 🌐 www.doctorvisitbangalore.com
Frequently Asked Questions About Kidney Cancer
What is kidney cancer? Kidney cancer develops when cells in the kidney grow abnormally and out of control, forming a tumour. The most common type is renal cell carcinoma (RCC), which accounts for 85 to 90% of all kidney cancers. In India, RCC accounts for approximately 3% of all cancers.
What are the early signs of kidney cancer? Kidney cancer rarely causes symptoms in early stages. The most common early sign — when it does appear — is blood in the urine (haematuria), which may make urine appear pink, red, or rust-coloured. Other symptoms include flank pain, a palpable abdominal mass, unexplained weight loss, persistent fatigue, and intermittent fever.
Is kidney cancer curable? Stage 1 and Stage 2 kidney cancer — confined to the kidney — is highly curable with surgery. Five-year survival rates for Stage 1 are 81 to 93%. Stage 3 is more serious but still treatable with surgery and systemic therapy. Stage 4 (metastatic) is not currently curable but modern targeted therapy and immunotherapy have significantly improved survival — some patients live for many years with good quality of life.
Can you live a normal life with one kidney after nephrectomy? Yes. Most people can live a completely normal, healthy life with a single kidney. The remaining kidney adapts over time and takes over the function of both kidneys. Kidney function should be monitored periodically after nephrectomy, and staying well hydrated and maintaining a healthy blood pressure becomes especially important.
What is the most common type of kidney cancer? Renal cell carcinoma (RCC) is the most common type, accounting for 85 to 90% of kidney cancers. Within RCC, clear cell renal cell carcinoma is the most common subtype — representing 70 to 75% of all RCC cases.
Does kidney cancer spread quickly? It depends on the subtype and grade. Clear cell RCC — the most common type — can vary from slow-growing low-grade tumours to aggressive high-grade cancers. Collecting duct RCC and unclassified RCC tend to be more aggressive. Chromophobe RCC is generally slow-growing. Regular follow-up after treatment is essential because kidney cancer can recur even years after initial treatment.
What is targeted therapy for kidney cancer? Targeted therapy drugs block specific molecules that kidney cancer cells depend on for growth — particularly the VEGF (vascular endothelial growth factor) pathway which promotes blood vessel growth in tumours. Key drugs include Sunitinib, Pazopanib, Axitinib, and Cabozantinib. These are taken as daily oral tablets and are the backbone of treatment for advanced clear cell RCC.
What is the difference between kidney cancer and kidney disease? Kidney disease — such as chronic kidney disease or kidney failure — involves the progressive loss of kidney function due to conditions like diabetes, hypertension, or inflammation. Kidney cancer is a malignant tumour growing within the kidney. They are entirely different conditions with different causes, treatments, and implications. However, chronic kidney disease is a risk factor for kidney cancer — particularly renal cell carcinoma — especially in long-term dialysis patients.
Can genetic testing predict kidney cancer risk? Yes — for certain hereditary kidney cancer syndromes including Von Hippel-Lindau disease, hereditary papillary renal cell carcinoma, and Birt-Hogg-Dubé syndrome. People with a family history of kidney cancer or known genetic syndromes should discuss genetic testing and enhanced surveillance with their doctor.
Is kidney cancer treatment available in India for international patients? Yes — India’s top cancer hospitals offer world-class kidney cancer treatment at 80 to 90% lower cost than Western countries. Doctor Visit Bangalore helps international patients from Africa, the Middle East, and Europe access the right uro-oncologist, arrange treatment, and coordinate their full journey including medical visa, accommodation, and follow-up.
What is the cost of kidney cancer treatment in India? Radical nephrectomy costs ₹2.5 lakh to ₹4 lakh for open surgery and ₹3 lakh to ₹5 lakh for laparoscopic surgery. Robotic partial nephrectomy costs ₹4 lakh to ₹7 lakh. Monthly targeted therapy drugs cost ₹30,000 to ₹1.5 lakh. Immunotherapy per cycle costs ₹1.5 lakh to ₹4 lakh. Contact Doctor Visit Bangalore for a personalised cost estimate based on your diagnosis and stage.
Can kidney cancer be prevented? Not completely, but risk can be significantly reduced by stopping smoking, maintaining a healthy weight, controlling blood pressure, staying well hydrated, and avoiding occupational chemical carcinogens. People with risk factors should have regular kidney function tests and imaging as recommended by their doctor.
Your Kidneys Are Worth Fighting For
Kidney cancer grows quietly. But when it is found — and when it is treated by the right specialists with the right tools — the outcomes can be excellent.
Bangalore’s kidney cancer specialists are among the most experienced in India. The hospitals are world-class. The targeted therapies and immunotherapy combinations now available have transformed what was once a very difficult cancer to treat into one where long-term survival is genuinely achievable — even in advanced stages.
Doctor Visit Bangalore is here to help you find the right uro-oncologist, understand your options, and make the journey from diagnosis to recovery as smooth as possible.
Contact us today. Your fight starts here — and we are with you.
📞 +91 78920 28951 💬 WhatsApp Now 🌐 doctorvisitbangalore.com
Arman Ali is the founder of Doctor Visit Bangalore, a trusted healthcare navigation platform helping patients find verified doctors, hospitals, and specialists across Bangalore and all over in India. With hands-on experience in healthcare research and patient assistance, Arman has personally helped hundreds of domestic and international patients connect with leading hospitals including Apollo, Manipal, Fortis, and Aster. His content is grounded in real hospital data, treatment cost research, and direct coordination with medical professionals across Bangalore. He specializes in medical tourism guidance, treatment cost transparency, and specialist discovery for complex conditions including cancer, cardiac surgery, and orthopedic care.